Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adapting the Goal Attainment Approach for Major Depressive Disorder.
McCue M, Parikh SV, Mucha L, Sarkey S, Cao C, Eramo A, Opler M, Webber-Lind B, François C. McCue M, et al. Among authors: parikh sv. Neurol Ther. 2019 Dec;8(2):167-176. doi: 10.1007/s40120-019-00151-w. Epub 2019 Aug 21. Neurol Ther. 2019. PMID: 31435869 Free PMC article.
Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study.
McCue M, Sarkey S, Eramo A, François C, Parikh SV. McCue M, et al. Among authors: parikh sv. BMC Psychiatry. 2022 Mar 7;22(1):170. doi: 10.1186/s12888-022-03798-2. BMC Psychiatry. 2022. PMID: 35255840 Free PMC article. No abstract available.
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report.
Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW; CAN-BIND Investigator Team. Morton E, et al. Among authors: parikh sv. Pharmacopsychiatry. 2021 Sep;54(5):225-231. doi: 10.1055/a-1385-0263. Epub 2021 Mar 2. Pharmacopsychiatry. 2021. PMID: 33652477
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Gilbert A, Burns L, Jablonski MR, Dechairo B. Greden JF, et al. Among authors: parikh sv. J Psychiatr Res. 2019 Apr;111:59-67. doi: 10.1016/j.jpsychires.2019.01.003. Epub 2019 Jan 4. J Psychiatr Res. 2019. PMID: 30677646 Free article. Clinical Trial.
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.
Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, Milev R, Harkness KL, Frey BN, Lam RW, Strother SC, Rotzinger S, Kennedy SH, MacQueen GM. Nogovitsyn N, et al. Among authors: parikh sv. Neuropsychopharmacology. 2020 Jan;45(2):283-291. doi: 10.1038/s41386-019-0542-1. Epub 2019 Oct 14. Neuropsychopharmacology. 2020. PMID: 31610545 Free PMC article.
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.
Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, McInerney S, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW; CAN-BIND Investigator Team. Morton E, et al. Among authors: parikh sv. CNS Drugs. 2021 Apr;35(4):439-450. doi: 10.1007/s40263-021-00803-2. Epub 2021 Apr 16. CNS Drugs. 2021. PMID: 33860922
270 results